NZ505897A - Method for producing (-)cis-3-hydroxy-1-methyl-4-(2,4,6- trimethoxyphenyl)-piperidine - Google Patents

Method for producing (-)cis-3-hydroxy-1-methyl-4-(2,4,6- trimethoxyphenyl)-piperidine

Info

Publication number
NZ505897A
NZ505897A NZ505897A NZ50589798A NZ505897A NZ 505897 A NZ505897 A NZ 505897A NZ 505897 A NZ505897 A NZ 505897A NZ 50589798 A NZ50589798 A NZ 50589798A NZ 505897 A NZ505897 A NZ 505897A
Authority
NZ
New Zealand
Prior art keywords
compound
vii
methyl
trimethoxyphenyl
hydrobromide
Prior art date
Application number
NZ505897A
Other languages
English (en)
Inventor
Gerhard Breipohl
Jurgen Michalowsky
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NZ505897A publication Critical patent/NZ505897A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NZ505897A 1998-01-23 1998-12-18 Method for producing (-)cis-3-hydroxy-1-methyl-4-(2,4,6- trimethoxyphenyl)-piperidine NZ505897A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19802449A DE19802449A1 (de) 1998-01-23 1998-01-23 Verfahren zur Herstellung von (-)cis-3-Hydroxy-1-methyl-4-(2,4,6-trimethoxypyhenyl)-piperidin
PCT/EP1998/008327 WO1999037615A1 (de) 1998-01-23 1998-12-18 Verfahren zur herstellung von (-)cis-3- hydroxy-1- methyl-4-(2, 4,6-trimethoxyphenyl)- piperidin

Publications (1)

Publication Number Publication Date
NZ505897A true NZ505897A (en) 2003-03-28

Family

ID=7855418

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ505897A NZ505897A (en) 1998-01-23 1998-12-18 Method for producing (-)cis-3-hydroxy-1-methyl-4-(2,4,6- trimethoxyphenyl)-piperidine

Country Status (26)

Country Link
US (1) US6225473B1 (show.php)
EP (1) EP1049674B1 (show.php)
JP (1) JP4585116B2 (show.php)
KR (1) KR100567941B1 (show.php)
CN (1) CN1137096C (show.php)
AR (1) AR015218A1 (show.php)
AT (1) ATE355270T1 (show.php)
AU (1) AU762407B2 (show.php)
BR (1) BR9814774B1 (show.php)
CA (1) CA2318946C (show.php)
CY (1) CY1106511T1 (show.php)
CZ (1) CZ298852B6 (show.php)
DE (2) DE19802449A1 (show.php)
DK (1) DK1049674T3 (show.php)
ES (1) ES2281943T3 (show.php)
HU (1) HU227928B1 (show.php)
IL (1) IL137422A (show.php)
NO (1) NO321933B1 (show.php)
NZ (1) NZ505897A (show.php)
PL (1) PL190790B1 (show.php)
PT (1) PT1049674E (show.php)
RU (1) RU2265595C2 (show.php)
SK (1) SK285883B6 (show.php)
TR (1) TR200002146T2 (show.php)
WO (1) WO1999037615A1 (show.php)
ZA (1) ZA99477B (show.php)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6437136B2 (en) * 1998-01-23 2002-08-20 Aventis Pharma Deutschland Gmbh Process for the preparation of (−)cis-3-hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl)piperidine
DE19809649A1 (de) * 1998-03-06 1999-09-09 Hoechst Marion Roussel De Gmbh Verfahren zur enzymatischen Enantiomeren-Trennung von 3(R)- und 3(S)-Hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl)-1,2,3,6-tetrahydro-pyridin bzw. der Carbonsäureester
AU2016252609B2 (en) 2015-04-20 2022-06-30 Sumitomo Pharma Oncology, Inc. Predicting response to alvocidib by mitochondrial profiling
HUE045585T2 (hu) 2015-05-18 2020-01-28 Tolero Pharmaceuticals Inc Megnövelt biológiai hozzáférhetõséggel rendelkezõ Alvocidib gyógyszer-elõanyagok
AU2016301315C1 (en) 2015-08-03 2022-07-07 Sumitomo Pharma Oncology, Inc. Combination therapies for treatment of cancer
WO2018094275A1 (en) 2016-11-18 2018-05-24 Tolero Pharmaceuticals, Inc. Alvocidib prodrugs and their use as protein kinase inhibitors
CA3047557A1 (en) 2016-12-19 2018-06-28 Tolero Pharmaceuticals, Inc. Profiling peptides and methods for sensitivity profiling
JP7196160B2 (ja) 2017-09-12 2022-12-26 スミトモ ファーマ オンコロジー, インコーポレイテッド Mcl-1阻害剤アルボシジブを用いた、bcl-2阻害剤に対して非感受性である癌の治療レジメン
US11034710B2 (en) 2018-12-04 2021-06-15 Sumitomo Dainippon Pharma Oncology, Inc. CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer
JP2022525149A (ja) 2019-03-20 2022-05-11 スミトモ ダイニッポン ファーマ オンコロジー, インコーポレイテッド ベネトクラクスが失敗した急性骨髄性白血病(aml)の処置
CN110577974B (zh) * 2019-09-10 2021-07-20 杭州澳赛诺生物科技有限公司 手性3-羟基-1,2,3,6-四氢吡啶的合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN164232B (show.php) * 1986-04-11 1989-02-04 Hoechst India
US5284856A (en) * 1988-10-28 1994-02-08 Hoechst Aktiengesellschaft Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one derivatives
DE3836676A1 (de) 1988-10-28 1990-05-03 Hoechst Ag Die verwendung von 4h-1-benzopyran-4-on-derivaten, neue 4h-1-benzopyran-4-on-derivate und diese enthaltende arzneimittel
US5849733A (en) * 1996-05-10 1998-12-15 Bristol-Myers Squibb Co. 2-thio or 2-oxo flavopiridol analogs
US5908934A (en) 1996-09-26 1999-06-01 Bristol-Myers Squibb Company Process for the preparation of chiral ketone intermediates useful for the preparation of flavopiridol and analogs

Also Published As

Publication number Publication date
IL137422A (en) 2005-11-20
AU2513599A (en) 1999-08-09
BR9814774A (pt) 2000-11-14
DK1049674T3 (da) 2007-06-25
DE59813924D1 (de) 2007-04-12
JP4585116B2 (ja) 2010-11-24
CZ298852B6 (cs) 2008-02-27
KR100567941B1 (ko) 2006-04-07
SK285883B6 (sk) 2007-10-04
NO20003454L (no) 2000-07-04
BR9814774B1 (pt) 2010-10-05
US6225473B1 (en) 2001-05-01
CY1106511T1 (el) 2012-01-25
IL137422A0 (en) 2001-07-24
AU762407B2 (en) 2003-06-26
PL342064A1 (en) 2001-05-21
EP1049674A1 (de) 2000-11-08
ES2281943T3 (es) 2007-10-01
SK10972000A3 (sk) 2000-12-11
HK1033319A1 (en) 2001-08-24
WO1999037615A1 (de) 1999-07-29
NO20003454D0 (no) 2000-07-04
NO321933B1 (no) 2006-07-24
AR015218A1 (es) 2001-04-18
DE19802449A1 (de) 1999-07-29
EP1049674B1 (de) 2007-02-28
CA2318946A1 (en) 1999-07-29
SK285883B9 (show.php) 2007-12-06
TR200002146T2 (tr) 2000-12-21
PT1049674E (pt) 2007-04-30
KR20010024867A (ko) 2001-03-26
ATE355270T1 (de) 2006-03-15
HUP0100649A3 (en) 2002-12-28
PL190790B1 (pl) 2006-01-31
HU227928B1 (en) 2012-06-28
ZA99477B (en) 1999-09-23
CA2318946C (en) 2009-11-03
RU2265595C2 (ru) 2005-12-10
JP2002501048A (ja) 2002-01-15
CN1137096C (zh) 2004-02-04
CN1284065A (zh) 2001-02-14
HUP0100649A1 (hu) 2001-07-30
CZ20002665A3 (cs) 2001-11-14

Similar Documents

Publication Publication Date Title
US5416215A (en) Process to preparing 2,2,6,6-tetra-methylpiperidine-n-oxyl and its 4-position substituted derivatives
KR950005196B1 (ko) I-데옥시노지리아미신 및 그의 n-유도체의 제조방법
Buckley et al. Mild and simple biomimetic conversion of amines to carbonyl compounds
Vedejs et al. Synthesis of N-methoxy and NH aziridines from alkenes
CY1106511T1 (el) Μεθοδος για την παρασκευη (-)cis-3-υδροξυ-1-μεθυλο-4-(2,4,6-τριμεθοξυφαινυλο)-πιπεριδινης
US5728836A (en) Process for preparing 4-acylamino-2,2,6,6-tetramethylpiperidines
DE112005000464T5 (de) Verfahren zum Herstellen von Hydroxystyrolen und acetylierten Derivaten davon
US8318942B2 (en) Process for preparing Donepezil and its derivatives
Yates One-pot conversion of olefins to carbonyl compounds by hydroboration/NMO-TPAP oxidation
RU2000122151A (ru) Способ получения (-)-цис-3-гидрокси-1-метил-4-(2,4,6-триметоксифенил) пиперидина
CA2352249C (en) Process for the synthesis of 5-(.alpha.-hydroxyalkyl) benzo[1,3]dioxols
CN110054632A (zh) 一种两步法制备5’-溴代烷氧基螺吡喃类化合物的合成方法
EP0431521A1 (en) Aminobutanol derivative and process for the preparation of 3-pyrrolidinol from the same
Zhang et al. Dimethylammonium Chlorochromate Adsorbed on Alumina: 1 A Mild, Convenient and Inexpensive Reagent for Cleavage of Carbon-Nitrogen Double Bonds Under Non-Aqueous Condition
CN1102143C (zh) 生产(9α,13α,14α)-1-(3-甲氧基吗啡喃-17-基)烷酮的方法
CA1280423C (en) Process for the preparation of dihydro-1h-pyrrolizine- 3,5-(2h,6h)-dione
US8507700B2 (en) Method of carbon chain extension using novel aldol reaction
Singh et al. Thebaine and acetylenic dienophiles
Martinez et al. Cyclic allylamine/enamine systems-6: Some reactions of 4-(indol-2-ylcarbonyl)-, 4-(indol-3-ylcarbonyl and 4-(indol-3-ylmethyl)-1, 2, 5, 6-tetrahydro-1-methylpyridines
WO2008114067A1 (en) Adamantane-dipyrromethane derivatives, method of preparation and applications in anion sensing
EP1431278A4 (en) METHOD OF PREPARING (2-NITROPHENYL) ACETONITRILE DERIVATIVES AND INTERMEDIATES THEREFOR
Claremon et al. Synthesis of 4, 5-dihydroazepine-3, 6-dicarboxylate derivatives by stereoselective ring expansion-nucleophilic addition to 4-. alpha.-chloroalkyl-1, 4-dihydropyridine-3, 5-dicarboxylates
EP0900787B1 (en) Process for preparing pyrrolidine derivatives
HU186528B (en) Process for producing tetronnoic acid
Anxin et al. An Expeditious Synthetic Route to Furolignans having Two Different Aryl Groups

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired